The mouse lymphoma assay

Methods in Molecular Biology

Volumn 817, Issue , 2012, Pages 35-54

  Lloyd, Melvyn ^a   Kidd, Darren ^a  

^a Department of Genetic and Molecular Toxicology   (United Kingdom)

Author keywords

Large and small colonies; Mouse lymphoma; Mutation; TFT; Thymidine kinase; Viability

Indexed keywords

DRUG DERIVATIVE; MUTAGENIC AGENT; THYMIDINE; THYMIDINE KINASE;

ANIMAL; ARTICLE; CELL SURVIVAL; DRUG EFFECT; GENE LOCUS; GENETICS; LEUKEMIA L 5178 Y; LYMPHOMA; METHODOLOGY; MOUSE; MUTAGEN TESTING; MUTATION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; GENETIC LOCI; LEUKEMIA L5178; LYMPHOMA; MICE; MUTAGENICITY TESTS; MUTAGENS; MUTATION; THYMIDINE; THYMIDINE KINASE;

EID: 84856004308     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-421-6_3     Document Type: Article

References (69)

1. OECD (1997) " In Vitro Mammalian Cell Gene Mutation Test", in: OECD Guidelines for the Testing of Chemicals, Test Guideline 476. OECD Paris (http://titania.sourceoecd.org/vl=1382924/cl=17/nw=1/rpsv/cw/vhosts/ oecdjournals/1607310x/v1n4/contp1-1. htm)
2. ICH, Topic S2B Genotoxicity: A Standard Battery for Genotoxocity Testing of Pharmaceuticals, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Step 4 Guideline, Brussels, July, 1997 (http://www.ich.org/cache/compo/502-272-1.html)
3. Law LW (1952) Increase in incidence of leukemia in hybrid mice bearing thymic transplants from a high leukemic strain. Journal of the National Cancer Institute 12 (4):789-805
4. Fischer GA (1958) Studies of the culture of leukemic cells in vitro. Annals of the New York Academy of Sciences 76 (3):673-680
5. Liechty MC, Hassanpour Z, Hozier JC and Clive D (1994) Use of microsatellite DNA polymorphisms on mouse chromosome 11 for in vitro analysis of thymidine kinase gene mutations. Mutagenesis 9:423-427 (Pubitemid 24297870)
6. Clive D, Flamm WG, Machesko MR and Bernheim NJ (1972) A mutational assay system using the thymidine kinase locus in mouse lym-phoma cells. Mutation Research 16: 77-87
7. Clive D (1973) Recent Developments with the L5178Y TK Heterozygote Mutagen Assay System. Environmental Health Perspectives 6: 119-125.
8. Moore-Brown MM, Clive D, Howard BE et al. (1981) The utilization of trifluorothymidine (TFT) to select for thymidine kinase-deficient (TK-/-) mutants from L5178Y/TK+/-mouse lymphoma cells. Mutation Research 85: 363-378 (Pubitemid 11059819)
9. Applegate ML, Moore MM, Broder CC, Burrell A., Juhn G., Kasweck KL, Lin P-F, Wadhams A and Hozier JC (1990) Molecular dissection of mutations at the heterozygous thymidine kinase locus in mouse lymphoma cells. Proceedings of the National Academy of Sciences USA 87:51-55
10. Moore MM, Clive D, Hozier JC et al. (1985) Analysis of trifluorothymidine-resistant (TFTr) mutants of L5178Y/TK+/-mouse lymphoma cells. Mutation Research 151:161-174 (Pubitemid 15023098)
11. Clive D and Spector JFS (1975) Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells. Mutation Research 31: 17-29.
12. Clive D and Voytek P (1977) Evidence for chemically-induced structural gene mutations at the thymidine kinase locus in cultured L5178Y mouse lymphoma cells. Mutation Research 44: 269-278. (Pubitemid 8162863)
13. Clive D, Johnson KO, Spector JFS et al. (1979) Validation and characterization of the L5178Y/TK+/-mouse lymphoma mutagen assay system. Mutation Research 59: 61-108 (Pubitemid 9070607)
14. Cole J, Arlett CF, Green MHL et al. (1983) A comparison of the agar cloning and microti-tration techniques for assaying cell survival and mutation frequency in L5178Y mouse lym-phoma cells. Mutation Research 111: 371-386 (Pubitemid 14211273)
15. Mitchell AD, Myhr BC, Rudd CJ et al. (1988) Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Methods used and chemicals evaluated. Environmental Mutagen-esis 12: 1-18
16. Mitchell AD, Rudd CJ and Caspary WJ (1988) Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Intralaboratory results for sixty-three coded chemicals tested at SRI international. Environmental Mutagenesis 12: 37-101
17. Caspary WJ, Daston DS, Myhr BC, et al. (1988) Evaluation of the L5178Y mouse lym-phoma cell mutagenesis assay: Interlaboratory reproducibility and assessment. Environmental Mutagenesis 12: 195-229
18. Caspary WJ, Lee YJ, Poulton S, et al. (1988) Evaluation of the L5178y mouse lymphoma cell mutagenesis assay: Quality-control guidelines and response categories. Environmental Mutagenesis 12: 19-36
19. Myhr BC and Caspary WJ (1988) Evaluation of the L5178Y mouse lymphoma cell mutagen-esis assay: Intralaboratory results for sixty-three coded chemicals tested at Litton Bionetics, Inc. Environmental Mutagenesis 12:103-194
20. Sawyer J, Moore MM, Clive D and Hozier J (1985) Cytogenetic characterization of the L5178Y TK+/-3.7.2C mouse lymphoma cell line. Mutation Research 147: 243-253 (Pubitemid 15235249)
21. +/- 3.7.2C mouse lymphoma cell line. Environmental and Molecular Mutagenesis 47: 127-131
22. Clive D, Turner NT, Krehl R and Eyre J (1985) The mouse lymphoma assay may be used as a chromosome aberration assay. Environmental Mutagenesis 7 (suppl. 3):33
23. ICH, Topic S2A Genotoxicity: Guidance on Specific Aspects of Regulatory Genotoxicity Tests
24. for Pharmaceuticals, International Conference on Harmonisation of Technical Reguirements for Registration of Pharmaceuticals for Human Use, Harmonised Tripartite Guideline CPMP/ICH/141/95, Approved September 1995 (http://www.ich.org/cache/compo/502-272-1.html)
25. -/mouse lymphoma mutants by loss of heterozy-gosity (LOH) and by whole chromosome 11 painting: detection or recombination. Mutagenesis 13 (5): 461-474 (Pubitemid 28458729)
26. Honma M, Hayashi M, Shimada H et al. (1999) Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis 14: 5-22 (Pubitemid 29048235)
27. Moore MM, Honma M, Clements J et al. (2000). Mouse Lymphoma Thymidine Kinase Locus Gene Mutation Assay: International Workshop on Genotoxicity Test Procedures Workgroup Report. Environmental and Molecular Mutagenesis 35:185-190 (Pubitemid 30196662)
28. Moore MM, Honma M, Clements J et al. (2002). Mouse lymphoma thymidine kinase gene mutation assay: follow-up International Workshop on Genotoxicity Test Procedures, New Orleans, Louisiana, April 2000. Environmental & Molecular Mutagenesis 40:292-9
29. Moore MM, Honma M, Clements J et al. (2003). Mouse Lymphoma Thymidine Kinase Locus Gene Mutation Assay: International Workshop on Genotoxicity Test Procedures Workgroup Report-Plymouth. UK 2002. Mutation Research 540:127-140
30. Moore MM, Honma M, Clements J et al. (2006). Mouse lymphoma thymidine kinase gene mutation assay: Follow-up meeting of the international workshop on Genotoxicity testing-Aberdeen, Scotland, 2003-Assay acceptance criteria, positive controls, and data evaluation. Environmental & Molecular Mutagenesis 47:1-5 (Pubitemid 43238018)
31. Moore MM, Honma M, Clements J et al. (2007). Mouse lymphoma thymidine kinase gene mutation assay: Meeting of the International Workshop on Genotoxicity Testing, San Francisco, 2005, recommendations for 24-h treatment. Mutation Research 627:36-40
32. Clive D, Bolcsfoldi G, Clements J, Cole J, Honma M, Majeska J, Moore M, Müller L, Myhr B, Oberly T, Ouldelhkim M-C, Rudd C, Shimada H, Sofuni T, Thybaud V and Wilcox P (1995), Consensus agreement regarding protocol issues discussed during the mouse lym-phoma workshop: Portland, Oregon, May 7, 1994, Environmental and Molecular Mutagenesis 25: 165-168
33. Han T, Wang J, Tong W, et al. (2006) Microarray analysis distinguished differential gene expression patterns from large and small colony Thymidine kinase mutants of L5178Y mouse lymphoma cells. BMC Bioinformatics 7 (Suppl 2):S9
34. Moore MM and Howard BE (1982) Quantitation of small colony trifluorothymi-dine-resistant mutants of L5178Y/TK+/-mouse lymphoma cells in RPMI-1640 medium. Mutation Research 104:287-294 (Pubitemid 12080308)
35. Brusick D (1986) Genotoxic effects in cultured mammalian cells produced by low ph treatment conditions and increased ion concentrations. Environmental Mutagenesis 8:879-886 (Pubitemid 17188042)
36. Scott D, Galloway SM, Marshall RR, Ishidate M Jr, Brusick D, Ashby J and Myhr BC (1991) Genotoxicity under extreme culture conditions. A repor t fr om ICPEMC Task Gr oup 9. Mutation Research 257:147-204
37. Robinson WD, Green MHL, Cole J, Garner RC, Healy MJR and Gatehouse D (1990) Statistical evaluation of bacterial/mammalian fluctuation tests. In Statistical Evaluation of Mutagenicity Test Data (Ed Kirkland DJ) Cambridge University Press, pp 102-140
38. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M and Weissenbach J (1994) The 1993-94 Genethon human genetic linkage map. Nat Genet 7:246-339 (Pubitemid 2086160)
39. Love JM, Knight AM, McAleer MA and Todd JA (1990) Towards construction of a high resolution map of the mouse genome using PCR-analysed microsatellites. Nucl. Acids Res. 18:4123-4130
40. Liechty MC, Crosby H, Murthy A, Davis LM, Caspary WJ and Hozier JC (1996) Identification of a heteromorphic microsatellite within the thymidine kinase gene in L5178Y mouse lym-phoma cells. Mutation Research 371:265-271 (Pubitemid 27036289)
41. Clive D, Glover P, Applegate M and Hozier J (1990) Molecular aspects of chemical muta-genesis in L5178Y/tk+/-mouse lymphoma cells. Mutagenesis 5:191-197 (Pubitemid 20274558)
42. +/- mouse lymphoma mutagenesis assay system. Mutation Research 84:169-181
43. Hozier J, Sawyer J, Clive D and Moore M (1982) Cytogenetic distinction between the TK+ and TK-chromosomes in the L5178Y TK+/-3.7.2C mouse-lymphoma cell line. Mutation Research 105:451-456 (Pubitemid 13247397)
44. +/- mutants early in their clonal history. Mutation Research 147:237-242 (Pubitemid 15235248)
45. r) mutants of L5178Y/TK+/-mouse-lymphoma cells. Mutation Research 151 147-159 (Pubitemid 15023097)
46. Moore MM, Clive D, Hozier JC, Howard. BE, Batson AG, Turner NT and Sawyer J. (1985) Analysis of trifluorothymidine-resistant (TFT ¢) mutants of L5178Y TK+/-mouse lymphoma cells. Mutation Research 151:161-174 (Pubitemid 15023098)
47. Blazak WF, Stewart BE, Galperin I, Allen KL, Rudd CJ, Mitchell AD and Caspary WJ (1986) Chromosome analysis of trifluorothymidine-resistant L5178Y mouse lymphoma cell colonies. Environmental Mutagenesis 8:229-240 (Pubitemid 16093364)
48. Liechty MC, Rauchfuss HS, Lugo MH and Hozier JC (1993) Sequence analysis of tka(-)-1 and tkb(+)-1 alleles in L5178Y tk+/-mouse-lymphoma cells and spontaneous tk-/-mutants Mutation Research 286:299-307 (Pubitemid 23103836)
49. Soriano C, Creus A and Marcos R (2008) Arsenic trioxide mutational spectrum analysis in the mouse lymphoma assay. Mutation Research 646:1-7
50. Chang C, Simmons DT, Martin MA and Mora PT (1979) Identification and partial characterization of new antigens from simian virus 40-transformed mouse cells. J Virol 31:463-471 (Pubitemid 9233893)
51. Kress M, May E, Cassingena R and May P (1979) Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum. J. Virol. 31:472-483 (Pubitemid 9233894)
52. Lane DP and Crawford LV (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278, 261-263 (Pubitemid 9129076)
53. Linzer DIH and Levine AJ (1979) Characterization of a 54 K dalton cellular SV40 tumor antigen resent in SV40-transformed cells and in infected embryonal carcinoma cells. Cell 17: 43-52. (Pubitemid 9188209)
54. Melero JA, Stitt DT, Mangel WF and Carroll RB (1979) Identification of new polypeptide species (48-55 K) immunoprecipitable by anti-serum to purified large T antigen and present in simian virus 40-infected and transformed cells. J. Virol. 93:466-480. (Pubitemid 9145500)
55. DeLeo A, Jay G, Appella E, Dubois GC, Law LW and Old LJ (1979) Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proceedings of the National Academy of Sciences, USA 76:2420-2424 (Pubitemid 9185501)
56. Crawford LV, Pim DC and Bulbrook RD (1982) Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int. J. Cancer 30: 403-408. (Pubitemid 12003724)
57. Maltzman W and Czyzyk L (1984) UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4:1689-1694 (Pubitemid 14008276)
58. Benchimol S., Matlashewski G. and Crawford L. (1984) The use of monoclonal antibodies for selection of a low-abundance mRNA: p53. Biochem Soc Trans 12(4):708-711
59. Wolf D and Rotter V (1985) Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proceedings of the National Academy of Sciences USA 82:790-794. (Pubitemid 15142764)
60. Caron de Fromentel C, May-Levin F, Mouriesse H, Lemerle J, Chandrasekaran K and May P (1987) Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma. Int. J. Cancer 39:185-189 (Pubitemid 17015278)
61. Harris SL and Levine AJ (2005) The p53 pathway: positive and negative feedback loops. Oncogene 24:2899-2908 (Pubitemid 40638098)
62. Colman MS, Afshar, CA and Barrett JC (2000) Regulation of p53 stability and activity in response to genotoxic stress. Mutation Research/Reviews in Mutation Research 462:179-188. (Pubitemid 30190225)
63. Jin S and Levine AJ (2001) The p53 functional circuit. J Cell Sci 114:4139-4140. (Pubitemid 33138651)
64. Levine AJ, Hu W and Feng Z (2006) The P53 pathway: what questions remain to be explored? Cell Death Differ 13:1027-1036.
65. Storer RD, Kraynak AR, McKelvey TW, Elia MC, Goodrow TL and DeLuca JG (1997) The mouse lymphoma L5178Y TK+/-cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor gene. Mutation Research 373:157-165 (Pubitemid 27478859)
66. Clark LS, Hart DW, Vojta PJ, Harrington-Brock K, Barrett JC, Moore MM and TIndall KR (1998) Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y Tk(+/-)-3.7.2C mouse lymphoma cells. Mutagenesis 13:427-434 (Pubitemid 28458725)
67. Kirkland D, Aardema M, Henderson L and Müller L (2005). Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: I. Sensitivity, specificity and relative predictivity. Mutation Research 584: 1-256 (Pubitemid 40922793)
68. Kirkland D, Aardema M, Müller L and Hayashi M (2006). Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens: II. Further analysis of mammalian cell results, relative predictivity and tumour profiles. Mutation Research 608: 29-42 (Pubitemid 44280041)
69. Kirkland D, Pfuhler S, Tweats D et al. (2007). How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop. Mutation Research 628:31-55